TOLECTIN Trademark

Trademark Overview


On Thursday, July 12, 2018, a trademark application was filed for TOLECTIN with the United States Patent and Trademark Office. The USPTO has given the TOLECTIN trademark a serial number of 88034829. The federal status of this trademark filing is REGISTERED as of Tuesday, April 16, 2019. This trademark is owned by Galt Pharmaceuticals, LLC. The TOLECTIN trademark is filed in the Pharmaceutical Products category with the following description:

Anti-inflammatories
tolectin

General Information


Serial Number88034829
Word MarkTOLECTIN
Filing DateThursday, July 12, 2018
Status700 - REGISTERED
Status DateTuesday, April 16, 2019
Registration Number5725500
Registration DateTuesday, April 16, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 29, 2019

Trademark Statements


Goods and ServicesAnti-inflammatories

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 16, 2018
Primary Code005
First Use Anywhere DateMonday, January 1, 2018
First Use In Commerce DateFriday, June 1, 2018

Trademark Owner History


Party NameGalt Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30339

Party NameGalt Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30339

Party NameGalt Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30339

Trademark Events


Event DateEvent Description
Wednesday, October 31, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, July 16, 2018NEW APPLICATION ENTERED
Monday, July 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 30, 2018ASSIGNED TO EXAMINER
Wednesday, October 31, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, October 31, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 31, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, December 4, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 26, 2018ASSIGNED TO LIE
Wednesday, January 9, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 29, 2019PUBLISHED FOR OPPOSITION
Tuesday, January 29, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 16, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, April 16, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, October 3, 2024TEAS SECTION 8 RECEIVED

Related Keywords


tolectin inflammatories anti